{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,7]],"date-time":"2026-06-07T10:07:15Z","timestamp":1780826835182,"version":"3.54.1"},"reference-count":23,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100010318","name":"University of Manitoba","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100010318","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Diagnostic Microbiology and Infectious Disease"],"published-print":{"date-parts":[[2021,10]]},"DOI":"10.1016\/j.diagmicrobio.2021.115447","type":"journal-article","created":{"date-parts":[[2021,6,4]],"date-time":"2021-06-04T18:01:38Z","timestamp":1622829698000},"page":"115447","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"title":["Invasive pneumococcal disease caused by serotypes 22F and 33F in Canada: the SAVE study 2011\u20132018"],"prefix":"10.1016","volume":"101","author":[{"given":"Alyssa R.","family":"Golden","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Fear","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melanie","family":"Baxter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heather J.","family":"Adam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Irene","family":"Martin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Walter","family":"Demczuk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James A.","family":"Karlowsky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"George G.","family":"Zhanel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.diagmicrobio.2021.115447_bib0001","first-page":"699","article-title":"The Quellung reaction, a neglected microbiologic technique","volume":"43","author":"Austrian","year":"1976","journal-title":"Mt Sinai J Med"},{"key":"10.1016\/j.diagmicrobio.2021.115447_bib0002","doi-asserted-by":"crossref","first-page":"2130","DOI":"10.1016\/j.vaccine.2009.12.026","article-title":"The effect of routine vaccination on invasive pneumococcal infections in Canadian children, Immunization Monitoring Program, Active 2000-2007","volume":"28","author":"Bettinger","year":"2010","journal-title":"Vaccine"},{"key":"10.1016\/j.diagmicrobio.2021.115447_bib0003","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1099\/jmm.0.000717","article-title":"Characterisation of Streptococcus pneumoniae isolates from invasive disease in adults following the introduction of PCV10 in Brazil","volume":"67","author":"Christophe","year":"2018","journal-title":"J Med Microbiol"},{"key":"10.1016\/j.diagmicrobio.2021.115447_bib0004","series-title":"Performance standards for antimicrobial susceptibility testing","year":"2020"},{"key":"10.1016\/j.diagmicrobio.2021.115447_bib0005","series-title":"Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically","year":"2018"},{"key":"10.1016\/j.diagmicrobio.2021.115447_bib0006","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1139\/cjm-2013-0614","article-title":"Serotype distribution of invasive Streptococcus pneumoniae in Canada after the introduction of the 13-valent pneumococcal conjugate vaccine, 2010-2012","volume":"59","author":"Demczuk","year":"2013","journal-title":"Can J Microbiol"},{"key":"10.1016\/j.diagmicrobio.2021.115447_bib0007","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0178040","article-title":"Phylogenetic analysis of emergent Streptococcus pneumoniae serotype 22F causing invasive pneumococcal disease using whole genome sequencing","volume":"12","author":"Demczuk","year":"2017","journal-title":"PLoS One"},{"key":"10.1016\/j.diagmicrobio.2021.115447_bib0008","doi-asserted-by":"crossref","first-page":"1","DOI":"10.14745\/ccdr.v36i00a12","article-title":"Update on the use of conjugate pneumococcal vaccines in childhood","volume":"36","author":"Desai","year":"2010","journal-title":"Canada Commun Dis Rep"},{"key":"10.1016\/j.diagmicrobio.2021.115447_bib0009","doi-asserted-by":"crossref","first-page":"6875","DOI":"10.1016\/j.vaccine.2018.03.012","article-title":"Safety and immunogenicity of 15-valent pneumococcal conjugate vaccine in pneumococcal vaccine-na\u00efve adults \u226550 years of age","volume":"36","author":"Ermlich","year":"2018","journal-title":"Vaccine"},{"key":"10.1016\/j.diagmicrobio.2021.115447_bib0010","doi-asserted-by":"crossref","first-page":"3197","DOI":"10.1016\/j.vaccine.2021.03.070","article-title":"Non-clinical immunological comparison of a Next-Generation 24-valent pneumococcal conjugate vaccine (VAX-24) using site-specific carrier protein conjugation to the current standard of care (PCV13 and PPV23)","volume":"39","author":"Fairman","year":"2021","journal-title":"Vaccine"},{"key":"10.1016\/j.diagmicrobio.2021.115447_bib0011","doi-asserted-by":"crossref","first-page":"1208","DOI":"10.1183\/13993003.01451-2015","article-title":"Effects of PCV7 and PCV13 on invasive pneumococcal disease and carriage in Stockholm, Sweden","volume":"47","author":"Galanis","year":"2016","journal-title":"Eur Respir J"},{"key":"10.1016\/j.diagmicrobio.2021.115447_bib0012","doi-asserted-by":"crossref","first-page":"2527","DOI":"10.1016\/j.vaccine.2016.03.058","article-title":"Invasive Streptococcus pneumoniae in Canada, 2011-2014: characterization of new candidate 15-valent pneumococcal conjugate vaccine serotypes 22F and 33F","volume":"34","author":"Golden","year":"2016","journal-title":"Vaccine"},{"key":"10.1016\/j.diagmicrobio.2021.115447_bib0013","doi-asserted-by":"crossref","first-page":"6883","DOI":"10.1016\/j.vaccine.2018.02.113","article-title":"Safety and immunogenicity of 15-valent pneumococcal conjugate vaccine (PCV15) in healthy infants","volume":"36","author":"Greenberg","year":"2018","journal-title":"Vaccine"},{"key":"10.1016\/j.diagmicrobio.2021.115447_bib0014","first-page":"ciaa1045","article-title":"Safety, tolerability, and immunogenicity of a 20-valent pneumococcal conjugate vaccine (PCV20) in adults 60 to 64 years of age","author":"Hurley","year":"2020","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.diagmicrobio.2021.115447_bib0015","doi-asserted-by":"crossref","first-page":"vii5","DOI":"10.1093\/jac\/dky156","article-title":"Antimicrobial susceptibility testing of invasive isolates of Streptococcus pneumoniae from Canadian patients: the SAVE study, 2011-15","volume":"73 Suppl 7","author":"Karlowsky","year":"2018","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.diagmicrobio.2021.115447_bib0016","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1016\/S1473-3099(19)30297-X","article-title":"Pneumococcal lineages associated with serotype replacement and antibiotic resistance in childhood invasive pneumococcal disease in the post-PCV13 era: an international whole-genome sequencing study","volume":"19","author":"Lo","year":"2019","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.diagmicrobio.2021.115447_bib0017","doi-asserted-by":"crossref","first-page":"60.e9","DOI":"10.1016\/j.cmi.2015.08.027","article-title":"Strain features and distributions in pneumococci from children with invasive disease before and after 13-valent conjugate vaccine implementation in the USA","volume":"22","author":"Metcalf","year":"2016","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.diagmicrobio.2021.115447_bib0018","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/S1473-3099(14)71081-3","article-title":"Effect of use of 13-valent pneumococcal conjugate vaccine in children on invasive pneumococcal disease in children and adults in the USA: analysis of multisite, population-based surveillance","volume":"15","author":"Moore","year":"2015","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.diagmicrobio.2021.115447_bib0019","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.vaccine.2015.11.015","volume":"34","author":"Nakano","year":"2016","journal-title":"Vaccine"},{"key":"10.1016\/j.diagmicrobio.2021.115447_bib0020","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1086\/648593","article-title":"Sustained reductions in invasive pneumococcal disease in the era of conjugate vaccine","volume":"201","author":"Pilishvili","year":"2010","journal-title":"J Infect Dis"},{"key":"10.1016\/j.diagmicrobio.2021.115447_bib0021","doi-asserted-by":"crossref","first-page":"309","DOI":"10.3389\/fmicb.2020.00309","article-title":"Clinical relevance and molecular pathogenesis of the emerging serotypes 22F and 33F of Streptococcus pneumoniae in Spain","volume":"11","author":"Sempere","year":"2020","journal-title":"Front Microbiol"},{"key":"10.1016\/j.diagmicrobio.2021.115447_bib0022","doi-asserted-by":"crossref","first-page":"5454","DOI":"10.1016\/j.vaccine.2020.06.040","article-title":"Antimicrobial susceptibility and clonality of Streptococcus pneumoniae isolates recovered from invasive disease cases during a period with changes in pneumococcal childhood vaccination, Norway, 2004\u20132016","volume":"38","author":"Siira","year":"2020","journal-title":"Vaccine"},{"key":"10.1016\/j.diagmicrobio.2021.115447_bib0023","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0226353","article-title":"The shifting epidemiology and serotype distribution of invasive pneumococcal disease in Ontario, Canada, 2007-2017","volume":"14","author":"Wijayasri","year":"2019","journal-title":"PLoS One"}],"container-title":["Diagnostic Microbiology and Infectious Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0732889321001401?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0732889321001401?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T09:56:05Z","timestamp":1760003765000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0732889321001401"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,10]]},"references-count":23,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2021,10]]}},"alternative-id":["S0732889321001401"],"URL":"https:\/\/doi.org\/10.1016\/j.diagmicrobio.2021.115447","relation":{},"ISSN":["0732-8893"],"issn-type":[{"value":"0732-8893","type":"print"}],"subject":[],"published":{"date-parts":[[2021,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Invasive pneumococcal disease caused by serotypes 22F and 33F in Canada: the SAVE study 2011\u20132018","name":"articletitle","label":"Article Title"},{"value":"Diagnostic Microbiology and Infectious Disease","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.diagmicrobio.2021.115447","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"115447"}}